Fluidra
€17.50Change from previous close: +1.80%Absolute change: +€0.31
At a glance
- Revenue growth
- +3.96%
- 2025 vs 2024
- Net income growth
- +27.49%
- 2025 vs 2024
- Net margin
- 7.9%
- 2024: 6.5%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 2,221 | 2,136 | 2,083 | 2,428 |
| Cost of revenue | 920 | 888 | 939 | 1,149 |
| Gross profit | 1,301 | 1,248 | 1,145 | 1,280 |
| Selling, general and administrative | 231 | 232 | 206 | 231 |
| Operating income | 308 | 262 | 250 | 304 |
| EBIT | 300 | 256 | 226 | 279 |
| EBITDA | 463 | 418 | 384 | 445 |
| Interest expense | 57.5 | 63.4 | 67.6 | 54.1 |
| Pre-tax income | 243 | 193 | 158 | 225 |
| Income tax | 64.0 | 51.0 | 41.3 | 60.7 |
| Net income | 176 | 138 | 114 | 160 |
| Net income to common shareholders | 176 | 138 | 114 | 160 |
| Basic EPS | 0.93 | 0.73 | 0.60 | 0.85 |
| Diluted EPS | 0.93 | 0.73 | 0.60 | 0.85 |
| Average shares (basic) | 190 | 190 | 190 | 189 |
| Average shares (diluted) | 190 | 190 | 190 | 189 |